NDC 10019-079 – Bendamustine Hydrochloride
Bendamustine Hydrochloride 100 mg/1 · Injection · Intravenous
Product NDC10019-079
Product details
- Brand name
- Bendamustine Hydrochloride
- Generic name
- Bendamustine hydrochloride
- Labeler
- Baxter Healthcare Corporation
- Dosage form
- Injection
- Route
- Intravenous
- Marketing category
- NDA · NDA216078
- Marketed since
- December 15, 2022
- Listing expires
- December 31, 2027
- Pharmacologic class
- Alkylating Drug
Active ingredients
- Bendamustine Hydrochloride 100 mg/1
Uses, dosage, side effects and warnings for Bendamustine Hydrochloride →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 10019-079-01 | 1 VIAL, MULTI-DOSE in 1 CARTON (10019-079-01) / 1 INJECTION in 1 VIAL, MULTI-DOSE | Dec 15, 2022 |
Recalls mentioning this NDC
- D-1103-2023 Aug 30, 2023 · Class III
Labeling: Missing Label; customer complaint received that labels were partially or completely peeled off injection vial.
Other Bendamustine Hydrochloride products
- 83831-183 Bendamustine Hydrochloride 100 mg/4mL · Injection · Avyxa Pharma, LLC
- 16729-250 Bendamustine Hydrochloride 25 mg/5mL · Injection, Powder, Lyophilized, For Solution · Accord Healthcare, Inc.
- 16729-251 Bendamustine Hydrochloride 100 mg/20mL · Injection, Powder, Lyophilized, For Solution · Accord Healthcare, Inc.
- 60505-6228 Bendamustine Hydrochloride 25 mg/mL · Injection, Solution · Apotex Corp
- 68001-572 Bendamustine Hydrochloride 100 mg/20mL · Injection, Powder, Lyophilized, For Solution · BluePoint Laboratories
- 55150-391 Bendamustine Hydrochloride 25 mg/5mL · Injection, Powder, Lyophilized, For Solution · Eugia US LLC
- 55150-392 Bendamustine Hydrochloride 100 mg/20mL · Injection, Powder, Lyophilized, For Solution · Eugia US LLC